Background: Endothelial dysfunction is thought to be a key event in the development of atherosclerosis. It is a systemic process that simultaneously affects different vascular territories including coronary arteries. It is recommended that noninvasive approaches assessing endothelial function in peripheral vessels like flow mediated dilatation are indirectly representative of coronary vascular function.
Introduction:
Endothelial dysfunction is thought to be a key event in the development of atherosclerosis (1). It is a systemic process that simultaneously affects different vascular territories. Coronary endothelial dysfunction is assessed using invasive methods, such as the infusion of acetylcholine (ACh) into the coronary artery that produces vasoconstriction in vessels with impaired endothelial function and atheroma (muscarinic effect) in the absence of nitric oxide release. Recently, it is recommended to use noninvasive approach to assess endothelial function in the peripheral vessels that is indirectly representative of coronary vascular function. Testing involves pharmacological and/or physiological stimulation of endothelial release of NO in these vessels with its subsequent influence on vascular tone. Currently the main noninvasive technique to assess endothelial functions is flow-mediated vasodilation (FMD) of the brachial artery as measured by using external vascular ultrasound (2) Flow-mediated dilatation (FMD) is a process that increases blood flow through an artery. This increase in the blood flow produces shear forces on the endothelium and subsequently stimulates endothelial cells to release NO (3). Reduced vasodilatation following an increase in shear forces is representative of impaired NO bioavailability (4). Therefore, FMD is a good marker of NO bioavailability. However, the FMD protocol involves a 5 minute occlusion of an artery, which causes tissue ischemia and when the cuff is released, a sudden increase in bloodflow (reactive hyperaemia) increases laminar shear forces parallel to the long axis of the vessel which is transduced via luminal mechanoreceptors to the endothelial cell. This event increases G-protein expression of phosphokinase A, signaling an increase of endothelial nitric oxide synthase (eNOS) activity which catalyzes the conversion of L-arginine to NO (5). NO then diffuses into the tunica media where it activates soluble guanylate cyclase which converts guanosine triphospate into guanosine monophospate to induce relaxation of the smooth muscle and subsequent vasodilation. FMD is expressed as the maximum percentage change in vessel diameter after cuff release relative to baseline vessel diameter (% FMD) (6), with a low percentage indicating poor endothelial function.
Assessment of endothelial dysfunction by flow mediated dilatation in patients with
Saba F.Salih Coronary Artery Disease from October 2013 till March 2015). 82 Participants of either sex with an age range (40-65years) were involved in this study. The participants were divided into two groups:
Patient group with Single coronary vessel lesion (n=51).
•
Control group with normal coronary CT angiography • (n=31). Systolic and diastolic blood pressures were measured for the right arm in a supine position after 10 minutes of rest using a standard mercury sphygmomanometer. Two readings were recorded and the average was considered. (7). The Flow mediated dilatation FMD test was performed in the morning (8-9 am) after a minimum 8-hour overnight fasting. Sonographic scans were performed after blood pressure measurements with a High Resolution, Multi-frequency (3-12-MHz) Linear array Ultrasound Doppler Probe equipped with HD11XE machine (Philips) with an attached electrocardiograph. (8). External vascular ultrasound imaging was performed by positioning Ultrasound probe longitudinally at approximately 5 cm proximal to the antecubital crease of the supinated and abducted right arm where the clearest image was obtained to measure brachial artery baseline diameter during systole and diastole according to the recommendations of the International Brachial Artery Task Force (9). The ultrasound Doppler system has an integrated electrocardiogram to synchronize the assessment of arterial diameter with the cardiac cycle, where a three-lead ECG system was used to ensure the timing and sequence of events in the brachial artery relative to the cardiac cycle. After a baseline measurement of brachial artery diameter synchronized with R wave which represents end-diastolic diameter, the sphygmomanometer cuff was inflated to about 50 mm Hg above systolic arterial pressure and this pressure was held for five minutes to induce ischemia in the forearm (10). Then, after 5 minutes occlusion, cuff was deflated. It is essential that the probe is held in the same position during the scan which is achieved by-pen marking the exact site where the brachial artery was visualized during the baseline diameters measurements. Blood flow was re-established by rapidly deflating the cuff, causing a reactive hyperemia following deflation, while brachial artery diameter is measured as soon as possible within 30-60 seconds while recording the FMD diameter, where FMD was defined as the maximal diameter seen within 60 seconds after cuff deflation. Determination of the diameter was performed at end-diastole synchronized with the R-wave of the electrocardiogram. All previous measurments were taken in freezed B mode of doppler sonography after identification of the artery versus the vein using a pulse wave (PW) and colour wave (CW) doppler. The angle of probe positioning is essential for better visualization of anterior and posterior arterial walls which ensures accurate measurement of the diameter. In addition to intimal thickness. (11).
Calculation of FMD
The calculation of FMD as a % change considers the peak diameter in response to reactive hyperemia in respect to the baseline diameter according to the following equation: FMD (%) = (PeakDiameter−BaselineDiameter)/Baseline Diameter × 100 (12). Coronary arteries were visualized by coronary CT aniography by using the 64 slice type (Philips, Holland, 2010) .Reducing a patient's heart rate before a scan was performed by administration of an oral β -blocker (50-100 mg) of oral metoprolol is administered 1 h before the scan or (5-20 mg) of intravenous metoprolol administered immediately before the scan. While sublingual nitroglycerin was administered to dilate the coronary arteries and increases side branches visualization (12). Three ECG leads are attached to obtain an adequate ECG tracing. Viscous intravenous contrast agent which is iodine (Omnipaque. Healthcare. Ireland) of (300-400 mg/mL) concentration at a high flow rate (4-6 mL/s) was injected. A special computer program creates two-dimensional cross-sectional images, which are then displayed on the monitor. A CT dataset for the coronary arteries covers the entire heart from the proximal ascending aorta to the diaphragmatic surface of the heart. (13). Maximum percent luminal stenosis was measured as: 100_ {(the area of residual patent lumen/the area of the normal adjacent vessels) ×100}. In this study, the data were analyzed using Microsoft Excel 2010. P -value <0.05 was considered to be statistically significant. The data were presented as mean ± SD. Statistical comparisons between two means were performed using unpaired Student's t-test. Pearson's correlation analysis was used to assess the possible relationships between study parameters.
Results:
In the current study, the functional marker (FMD %) revealed an inverse correlation with a percentage of coronary artery stenosis as a structural marker of atherosclerosis in patients with single coronary vessel involvement by atherosclerotic lesion (p value <0.01) (figure 1). FMD in patients having a single coronary vessel atheromatous stenosis (9.9±3.5) % was significantly lower than that of control subjects (15.3±7) %, p<0.0001.
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Discussion:
Endothelial-dependent vascular consequencesare important medical issue in the initiation, progression of atherosclerosis and in the transition from a reversible to irreversible disease status. The flow mediated dilatation not only reflecting integrity of vascular endothelium, but also extend beyond that to reflect the coronary structural changes which are proved, in the current study, by an inverse correlation between the FMD% with the percentage of coronary artery stenosis in SCL patients. These findings are in agreement with the two studies performed by Mulukutla et al., 2010 (14) and Schnabel et al., 2012 (15) who proved that FMD reflects the functional physiology of the coronary endothelium and the impairment of FMD could proceed to the coronary structural changes revealed by atheroma. The biological link between vascular endothelial damage and the pathogenesis of atherosclerosis may be due to the diminished arterial bioavailability of NO, which may be the predisposing factor to leucocyte and platelet adhesion, smooth muscle cell proliferation and vasoconstriction because under normal conditions, endothelial NO not only produces vasodilatation, but it also reduces migration and growth of vascular smooth muscle cell, platelet aggregation and subsequent thrombosis, monocyte and macrophage adhesion and inflammation (Bonetti, Lerman and Lerman, 2003) (16) . Therefore, this impairment in endothelial function plays a principal role in the pathophysiology of coronary artery atheromatous diseases. The lower mean brachial artery FMD percentages in patients with coronary artery stenosis when compared with that of controls are in accordance with a previous study performed by Yeboah et al., 2009(17) who concluded that brachial FMD is considered as a predictor of coronary artery disease.
